Fundz

Who to call at CytomX Therapeutics, Inc., and when

Fundz watches for the moments CytomX Therapeutics, Inc. starts buying, and tells you who to reach.

  • An alert the day CytomX Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CytomX Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CytomX Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

CytomX Therapeutics Achieves $5 Million Milestone in Partnership with Regeneron for Bispecific Antibody Development.

Nov 17, 2026

Contract Type

partnership

San FranciscoBiotechnology

Description

CytomX Therapeutics has announced a preclinical milestone achievement in its strategic collaboration with Regeneron, resulting in a $5 million milestone payment. The partnership aims to develop bispecific antibodies that activate in the tumor microenvironment, enhancing cancer treatment options.

Quick answer

CytomX Therapeutics Achieves $5 Million Milestone in Partnership with Regeneron for Bispecific Antibody Development. (November 17, 2026). CytomX Therapeutics, Inc. is based in San Francisco, California, United States.

What agreement did CytomX Therapeutics, Inc. announce on November 17, 2026?
CytomX Therapeutics has announced a preclinical milestone achievement in its strategic collaboration with Regeneron, resulting in a $5 million milestone payment. The partnership aims to develop bispecific antibodies that activate in the tumor microenvironment, enhancing cancer treatment options.
What does CytomX Therapeutics, Inc. do?
CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform.
Where is CytomX Therapeutics, Inc. based?
CytomX Therapeutics, Inc. is based in San Francisco, California, United States.
Which similar companies announced agreements around the same time?
Kernal Biologics (November 17, 2026), Amoéba (November 17, 2026), AcouSort AB (November 17, 2026) and Ainos, Inc. (November 17, 2026) also announced agreements within 45 days of CytomX Therapeutics, Inc.

Source: Fundz verified event record.

Other recent agreements in Biotechnology

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

CytomX Therapeutics, Inc.

Location

San Francisco, California, United States

About

CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform. We have a broad pipeline comprised of five clinical-stage programs, with even more in development. Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation, and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes and holding each other to the highest possible standards. CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected and connected. We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population. CytomX acknowledges the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category. CytomX is located in South San Francisco, California, the birthplace of biotechnology. Learn more about us and how we are advancing science to treat cancer differently at www.cytomX.com.

Related People

Sean
Likely contact at this company
••••••••@••••••••

See Sean's verified email →

Swati
Likely contact at this company
••••••••@••••••••

See Swati's verified email →

Stu
Senior decision-maker at this company
••••••••@••••••••

See Stu's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CytomX Therapeutics, Inc.'s next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

CytomX Therapeutics, Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.